Two-dimensional (2D) Dion−Jacobson (DJ) perovskite solar cells (PSCs), despite their advantage in versatility of n-layer variation, are subject to poor photovoltaic efficiency, particularly in the fill factor (FF), compared to their three-dimensional counterparts. To enhance the performance of DJ PSCs, the process of growing crystals and hence the corresponding morphology of DJ perovskites are of prime importance. Herein, we report the fast nonisothermal (NIT) crystallization protocol that is previously unrecognized for 2D perovskites to significantly improve the morphology, orientation, and charge transport of the DJ perovskite films. Comprehensive mechanistic studies reveal that the NIT effect leads to the secondary crystallization stage, forming network-like channels that play a vital role in the FF's leap-forward improvement and hence the DJ PSC's performance. As a whole, the NIT crystallized PSCs demonstrate a high power conversion efficiency and an FF of up to 19.87 and 86.16%, respectively. This research thus provides new perspectives to achieve highly efficient DJ PSCs.
A series of tailor-made highly efficient and near-infrared (NIR) porphyrin-based acceptors is designed and synthesized for fullerene-free bulk-heterojunction (BHJ) organic solar cells. Constructing BHJ active layers using a PTB7-Th donor and porphyrin acceptors (P-x), which have complementary absorption, accomplishes panchromatic photon-to-current conversion from 300 to 950 nm. Our study shows that side chains of the porphyrin acceptors fairly influence the molecular ordering and nanomorphology of the BHJ active layers. Significantly, the porphyrin acceptor with four dodecoxyl side chains (P-2) achieves an open-circuit voltage (V OC ) of 0.80 V, short-circuit current density (J SC ) of 13.94 mA cm −2 , fill factor of 64.8%, and overall power conversion efficiency of 7.23%. This great performance is attributable to the ascendant light-harvesting capability in the visible and near-infrared region, a high-lying LUMO energy level, a relatively high and more balanced carrier mobilities, and more ordered face-on molecular packing, which is beneficial for obtaining high V OC and J SC .
In this Letter, two zinc porphyrin small molecules D1 and A1 with different functional groups have been employed as the donor and acceptor, respectively, for the construction of all-porphyrin photovoltaics (APPs). The strong electron-donating phenylamino moiety ensures the D1 small molecule with a high-lying highest occupied molecular orbital energy level aligns a cascade energy level with the A1 small molecule, accomplishing the driving force for exciton dissociation and prompting intermolecular π−π stacking to ameliorate the intermolecular charge transport. Meanwhile, good complementary absorptions between D1 donor and A1 acceptor greatly contribute to harvesting more solar flux. For the optimized devices, 1:0.5 D1:A1 device delivered a relatively high power conversion efficiency of 7.21% with an open-circuit voltage of 0.76 V, a short-circuit current density of 14.43 mA cm −2 , a fill factor of 65.7%, and a small energy loss of 0.61 eV.
Efficient control
of the perovskite crystallization
and passivation of the defects at the surface and grain boundaries
of perovskite films have turned into the most important strategies
to restrain charge recombination toward high-performance and long-term
stability of perovskite solar cells (PSCs). In this paper, we employed
a small amount of natural vitamin B (carnitine) with dual functional
groups in the MAPbI3 precursor solution to simultaneously
passivate the positive- and negative-charged ionic defects, which
would be beneficial for charge transport in the PSCs. In addition,
such methodology can efficiently ameliorate crystallinity with texture,
better film morphology, high surface coverage, and longer charge carrier
lifetime, as well as induce preferable energy level alignment. Benefiting
from these advantages, the power conversion efficiency of PSCs significantly
increases from 16.43 to 20.12% along with not only a higher open-circuit
voltage of 1.12 V but also an outstanding fill factor of 82.78%.
Inverted perovskite
solar cells (PSCs) have attracted intense attention
because of their insignificant hysteresis and low-temperature fabrication
process. However, the efficiencies of inverted PSCs are still inferior
to those of commercialized silicon solar cells. Also, the poor stability
of PSCs is one of the major impedances to commercialization. Herein,
we rationally designed and synthesized a new series of electron donor
(
R
,
R
-diphenylamino) and acceptor
(pyridimium-(CH
2
)
n
-sulfonates)
zwitterions as a boundary modulator and systematically investigated
their associated interface properties. Comprehensive physical and
optoelectronic studies verify that these zwitterions provide a four-in-one
functionality: balancing charge carrier transport, suppressing less-coordinated
Pb
2+
defects, enhancing moisture resistance, and reducing
ion migration. Although each functionality may have been reported
by specific passivating molecules, a strategy that simultaneously
regulates the charge-transfer balance and three other functionalities
has not yet been developed. The results are to make an omnidirectional
improvement of PSCs. Among all zwitterions, 4-(4-(4-(di-(4-methoxylphenyl)amino)phenyl)propane-1-ium-1-yl)butane-1-sulfonate
(OMeZC3) optimizes the balance hole/electron mobility ratio of perovskite
to 0.91, and the corresponding PSCs demonstrate a high power conversion
efficiency (PCE) of up to 23.15% free from hysteresis, standing out
as one of the champion PSCs with an inverted structure. Importantly,
the OMeZC3-modified PSC exhibits excellent long-term stability, maintaining
almost its initial PCE after being stored at 80% relative humidity
for 35 days.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.